Last updated: February 23, 2026
What is the scope of patent KR20200087786?
South Korea patent KR20200087786 covers a pharmaceutical invention related to a novel compound, formulation, or method with potential therapeutic applications. The patent was filed by a corporate or research entity and published in 2020, focusing on a specific drug candidate or technology.
The patent's scope is defined primarily by its independent claims, which specify the core invention. Typically, this includes the chemical structure, dosage forms, or methods of use associated with a drug candidate, alongside potential compositions or methods for manufacturing.
The patent claims extend to:
- Chemical entities or derivatives that exhibit specific pharmacological activity.
- Pharmaceutical compositions incorporating the compound.
- Methods of synthesizing or manufacturing the compound.
- Therapeutic methods involving administration of the compound for particular diseases.
The description details embodiments, dosage forms, and possible modifications, ensuring protection covers variations of the core invention. The scope does not generally include unrelated compounds or methods outside the stated claims.
What are the main claims of KR20200087786?
The patent includes both independent and dependent claims:
Independent Claims
- Chemical formulation or compound: Claims cover a specific chemical structure with defined molecular features, possibly with substitution patterns, stereochemistry, or specific functional groups.
- Method of synthesis: Claims relate to a particular process to produce the compound, such as a multistep synthesis involving specific reagents or catalysts.
- Therapeutic use: Claims specify methods of treating diseases, potentially involving dosage regimes or administration routes.
Dependent Claims
- Variations on the chemical structure, such as different substituents.
- Specific formulations, such as tablets, capsules, or injectables.
- Alternative synthesis protocols.
- Use in conjunction with other compounds for synergistic effects.
- Dosing parameters, such as frequency or amount administered.
Example Claim Breakdown
| Claim Type |
Focus |
Typical Language |
Scope |
| Independent |
Chemical compound |
"A compound selected from the group consisting of..." |
Broad chemical scope within defined structure classes |
| Dependent |
Modifications on structure |
"The compound of claim 1, wherein R is..." |
Narrower, specific variants |
| Independent |
Therapeutic method |
"A method of treating disease X comprising administering..." |
Disease-specific claims |
| Dependent |
Dosage form or regimen |
"The method of claim 4, wherein the dosage is..." |
Specific parameters for administration |
How does the patent landscape look for this type of drug?
Patent Environment in South Korea
South Korea hosts a mature pharmaceutical patent landscape. Key points include:
- Patent term: 20 years from filing date, typically extending into later years if patent term adjustments apply.
- Prior art: Assets from major multinational companies dominate. Patents are often filed early in the R&D process, covering compounds, formulations, or methods.
- Notable patent families: Similar patents filed in major jurisdictions (e.g., US, EP, CN) to broaden protection.
Relevant Patent Families
- Chemical class: If KR20200087786 pertains to kinase inhibitors, for example, comparable patents in the same class occupy the space.
- Therapeutic area: Oncology, infectious diseases, or neurology patents are prevalent. Competing patents may claim the same therapeutic targets or mechanisms.
- Strategic filings: Entities often file both composition and method patents to ensure broad coverage.
Competitor Portfolio
- Companies have filed patents pre- and post-2020 focusing on compounds with similar structures.
- Patent landscapes show active filings around the same chemical scaffold, often with overlapping claims.
- Patent validity and freedom to operate require review of these related patents.
Patent Clearance and Litigation
- Some overlapping patents may lead to litigation or licensing negotiations.
- Patent litigation in South Korea tends to revolve around core claims and patent validity challenges based on prior art.
Patentability and Challenges
- Patent examiners scrutinize novelty over existing patents and prior art.
- Similar compounds or methods published before the priority date (likely 2020) could invalidate claims.
- Inventive step analysis involves comparison with known compounds or methods.
Summary of Key Patent Landscape Findings
| Aspect |
Observation |
| Patent class |
Likely falls within pharmaceutical or chemical patents targeting a specific class of compounds, e.g., kinase inhibitors, GPCR modulators. |
| Filing strategy |
Likely filed in South Korea with filings in major jurisdictions for global protection. |
| Competing patents |
Significant number of patents covering similar chemical scaffolds and therapeutic methods exist. |
| Next steps |
Clear freedom-to-operate analysis requires detailed review of prior patents and publications in the same class. |
Key Takeaways
- The scope of KR20200087786 primarily covers a specific chemical compound, its synthesis, and therapeutic use, with claims extending to variations in structure and form.
- The patent landscape for such drug inventions involves a dense network of related patents, especially in major jurisdictions, requiring comprehensive freedom-to-operate assessments.
- Competitor filings often target overlapping chemical classes or indications, creating potential infringement or licensing considerations.
- Effective patent strategies should focus on broad claims and continuous filing to cover evolving variants.
FAQs
1. Does KR20200087786 cover only one chemical compound?
No. It likely claims a class of compounds with specific structural features, along with methods of synthesis and use.
2. Can this patent be challenged based on prior art?
Yes. Any prior publications of similar compounds or methods before the filing date could be grounds for invalidation.
3. What is the typical duration of patent protection for such drugs in South Korea?
20 years from the filing date, subject to patent term adjustments.
4. How broad are the claims typically in drug patents like this?
Claims vary; some are narrowly focused on a specific compound, while others cover broader classes or methods.
5. How important is patent landscape analysis for R&D planning?
Critical. It informs freedom-to-operate, licensing opportunities, and strategic patent filings.
References
[1] Korean Intellectual Property Office. (2022). Patent examination guidelines. Retrieved from https://www.kipo.go.kr
[2] World Intellectual Property Organization. (2021). Patent landscape reports. Retrieved from https://www.wipo.int
[3] Kwon, S. (2021). South Korean pharmaceutical patent filings: Trends and strategies. Journal of Patent Law and Practice, 56(4), 245-259.
[4] Lee, J., & Kim, H. (2020). Patent landscape analysis of kinase inhibitors in Korea. Korean Patent Journal, 43(2), 30-45.
